HELPING THE OTHERS REALIZE THE ADVANTAGES OF GM-CSF/CSF2 PROTEIN

123). It's notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This means that GLS2 could confer resistance to GLS1-specific inhibitors, such as the allosteric inhibitor BPTES or CB-839, which resistance could possibly be hypothetically averted by the usage